[1]
Eley, B.M.; Manson, J.D. Outline of Periodontics, 4th ed; , 2000.
[2]
Lindhe, J.; Lang, N.P.; Karring, T. Clinical Periodontology and Implant Dentistry, 5th ed; , 2008.
[3]
Newman, M.G.; Takei, H.H.; Klokkevold, P.R.; Carranza, F.A., Jr Carranza’s Clinical Periodontology, 11th ed; , 2012.
[4]
Suhag, A.; Dixit, J.; Dhan, P. Role of curcumin as a subgingival irrigant: a pilot study. Periodontal Practice Today, 2007, 4(2), 115-121.
[5]
Muglikar, S.; Patil, K.C.; Shivswami, S.; Hegde, R. Efficacy of curcumin in the treatment of chronic gingivitis: a pilot study. Oral Health Prev. Dent., 2013, 11(1), 81-86.
[6]
Nagpal, M.; Sood, S. Role of curcumin in systemic and oral health: An overview. J. Nat. Sci. Biol. Med., 2013, 4(1), 3-7.
[7]
Chaturvedi, T.P. Uses of turmeric in dentistry: an update. Indian J. Dent. Res., 2009, 20(1), 107-109.
[8]
Kohli, K.; Ali, J.; Ansari, M.J.; Raheman, Z. Curcumin: A natural anti-inflammatory agent. Indian J. Pharmacol., 2005, 37, 141-147.
[9]
Sidhu, G.S.; Singh, A.K.; Thaloor, D.; Banaudha, K.K.; Patnaik, G.K.; Srimal, R.C.; Maheshwari, R.K. Enhancement of wound healing by curcumin in animals. Wound Repair Regen., 1998, 6(2), 167-177.
[10]
Menon, V.P.; Sudheer, A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol., 2007, 595, 105-125.
[11]
Jurenka, J.S. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern. Med. Rev., 2009, 14(2), 141-153.
[12]
Thakur, N.; Ghezta, N. Curcumin. Guident, 2012, 5(5), 76-79.
[13]
Christodoulides, N.; Floriano, P.N.; Miller, C.S.; Ebersole, J.L.; Mohanty, S.; Dharshan, P.; Griffin, M.; Lennart, A.; Ballard, K.L.; King, C.P., Jr; Langub, M.C.; Kryscio, R.J.; Thomas, M.V.; McDevitt, J.T. Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann. N. Y. Acad. Sci., 2007, 1098, 411-428.
[14]
Sexton, W.M.; Lin, Y.; Kryscio, R.J.; Dawson, D.R., III; Ebersole, J.L.; Miller, C.S. Salivary biomarkers of periodontal disease in response to treatment. J. Clin. Periodontol., 2011, 38(5), 434-441.
[15]
Thunell, D.H.; Tymkiw, K.D.; Johnson, G.K.; Joly, S.; Burnell, K.K.; Cavanaugh, J.E.; Brogden, K.A.; Guthmiller, J.M. A multiplex immunoassay demonstrates reductions in gingival crevicular fluid cytokines following initial periodontal therapy. J. Periodontal Res., 2010, 45(1), 148-152.
[16]
Grover, V.; Malhotra, R.; Sachdeva, S. Cytokines: the signaling molecules of periodontium, 1st ed; , 2011.
[17]
Kaushik, R.; Yeltiwar, R.K.; Pushpanshu, K. Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study. J. Periodontol., 2011, 82(9), 1353-1359.
[18]
Miller, C.S.; King, C.P., Jr; Langub, M.C.; Kryscio, R.J.; Thomas, M.V. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J. Am. Dent. Assoc., 2006, 137(3), 322-329.
[19]
Gomes, F.I.; Aragão, M.G.; Barbosa, F.C.; Bezerra, M.M.; de Paulo Teixeira Pinto, V.; Chaves, H.V. Inflammatory Cytokines Interleukin-1β and Tumour Necrosis Factor-α - Novel Biomarkers for the Detection of Periodontal Diseases: a Literature Review. J. Oral Maxillofac. Res., 2016, 7(2)e2
[20]
Sakalauskiene, J.; Giedrimiene, D.; Gleiznys, D.; Gleiznys, A.; Gleizniene, R.; Vitkauskiene, A. Peripheral Blood Leukocytes Interleukin-1 Beta (IL-1β) Cytokine Hyper-Reactivity in Chronic Periodontitis. Med. Sci. Monit., 2016, 22, 4323-4329.
[21]
Sexton, W.M.; Lin, Y.; Kryscio, R.J.; Dawson, D.R., III; Ebersole, J.L.; Miller, C.S. Salivary biomarkers of periodontal disease in response to treatment. J. Clin. Periodontol., 2011, 38(5), 434-441.
[22]
Ciancio, S.G. Current status of indices of gingivitis. J. Clin. Periodontol., 1986, 13(5), 375-378, 381-382.
[23]
Behal, R.; Mali, A.M.; Gilda, S.S.; Paradkar, A.R. Evaluation of local drug-delivery system containing 2% whole turmeric gel used as an adjunct to scaling and root planing in chronic periodontitis: A clinical and microbiological study. J. Indian Soc. Periodontol., 2011, 15(1), 35-38.
[24]
Gottumukkala, S.N.V.S.; Koneru, S.; Mannem, S.; Mandalapu, N. Effectiveness of sub gingival irrigation of an indigenous 1% curcumin solution on clinical and microbiological parameters in chronic periodontitis patients: A pilot randomized clinical trial. Contemp. Clin. Dent., 2013, 4(2), 186-191.
[25]
Gottumukkala, S.N.V.S.; Sudarshan, S.; Mantena, S.R. Comparative evaluation of the efficacy of two controlled release devices: Chlorhexidine chips and indigenous curcumin based collagen as local drug delivery systems. Contemp. Clin. Dent., 2014, 5(2), 175-181.
[26]
Engebretson, S.P.; Grbic, J.T.; Singer, R.; Lamster, I.B. GCF IL-1beta profiles in periodontal disease. J. Clin. Periodontol., 2002, 29(1), 48-53.
[27]
Offenbacher, S.; Barros, S.P.; Singer, R.E.; Moss, K.; Williams, R.C.; Beck, J.D. Periodontal disease at the biofilm-gingival interface. J. Periodontol., 2007, 78(10), 1911-1925.
[28]
Greenstein, G. Clinical versus statistical significance as they relate to the efficacy of periodontal therapy. J. Am. Dent. Assoc., 2003, 134(5), 583-591.